Dasatinib
Dasatinib
Dasatinib is multitarget kinase inhibitor used in the treatment of leukemia. Dasatinibs main targets are tyrosine kinase BCR/ABL, which works to provide the cancer cell with ATP at an uncontrolled rate causing rapid division, and the SRC family o
Octreotide (acetate)